Fulgent Q3 2023 EPS $(0.39) Misses $(0.33) Estimate, Revenue $66M Beats $63.4M Estimate
Portfolio Pulse from Benzinga Newsdesk
Fulgent Genetics (FLGT) reported Q3 2023 earnings per share (EPS) of $(0.39), missing the estimate of $(0.33). However, the company's revenue of $66M surpassed the estimate of $63.4M.
November 03, 2023 | 11:04 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Fulgent Genetics' Q3 2023 EPS missed estimates, but revenue beat expectations. This mixed result could lead to uncertain short-term price movements.
Fulgent Genetics' EPS missed the estimate, which could negatively impact the stock price. However, the company's revenue beat the estimate, which could have a positive effect. These mixed results make the short-term price direction uncertain.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100